Alteryx (NYSE:AYX) had its price objective upped by DA Davidson to $123.00 in a research note issued to investors on Thursday morning, The Fly reports. DA Davidson currently has a neutral rating on the stock.
A number of other equities research analysts have also weighed in on AYX. Citigroup set a $153.00 price objective on Alteryx and gave the company a buy rating in a research note on Friday, July 26th. Oppenheimer raised their price objective on Alteryx from $93.00 to $120.00 and gave the company an outperform rating in a research note on Monday, June 17th. Guggenheim initiated coverage on Alteryx in a research note on Thursday, June 27th. They set a buy rating and a $107.53 price objective for the company. Bank of America raised their price objective on Alteryx from $126.00 to $140.00 and gave the company a buy rating in a research note on Thursday. Finally, Cowen raised their price objective on Alteryx from $112.00 to $137.00 and gave the company an outperform rating in a research note on Wednesday, June 26th. Four research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The stock presently has an average rating of Buy and an average target price of $116.82.
Shares of AYX stock traded down $1.41 during trading hours on Thursday, reaching $130.16. The company had a trading volume of 1,309,886 shares, compared to its average volume of 1,009,485. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 0.07. Alteryx has a twelve month low of $41.66 and a twelve month high of $133.93. The stock has a market capitalization of $7.35 billion, a P/E ratio of -650.80, a P/E/G ratio of 49.78 and a beta of 1.24. The company’s fifty day simple moving average is $113.99.
In other Alteryx news, insider Robert Scott Jones sold 1,598 shares of the stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $94.63, for a total transaction of $151,218.74. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Christopher M. Lal sold 5,000 shares of the stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $90.59, for a total value of $452,950.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 124,763 shares of company stock valued at $12,253,528. 19.82% of the stock is owned by insiders.
Large investors have recently added to or reduced their stakes in the business. Sageworth Trust Co bought a new position in Alteryx during the 1st quarter worth approximately $27,000. FNY Investment Advisers LLC bought a new position in Alteryx during the 2nd quarter worth approximately $80,000. Penserra Capital Management LLC lifted its holdings in Alteryx by 70.7% during the 1st quarter. Penserra Capital Management LLC now owns 1,265 shares of the company’s stock worth $106,000 after buying an additional 524 shares during the last quarter. Aperio Group LLC bought a new position in Alteryx during the 2nd quarter worth approximately $156,000. Finally, Advisory Services Network LLC bought a new position in Alteryx during the 2nd quarter worth approximately $171,000. 64.29% of the stock is currently owned by institutional investors.
Alteryx Company Profile
Alteryx, Inc operates a self-service data analytics software platform that enables organizations to enhance business outcomes and the productivity of their business analysts, data scientists, and citizen data scientists worldwide. Its software platform includes Alteryx Designer, a data profiling, preparation, blending, and analytics product used to create visual workflows or analytic processes; Alteryx Server, a server-based product for scheduling, sharing, and running analytic processes and applications in a Web-based environment; Alteryx Connect, a collaborative data exploration platform for discovering information assets and sharing recommendations across the enterprise; and Alteryx Promote, an analytics model management product for data scientists and analytics teams to build, manage, monitor, and deploy predictive models into real-time production applications.
Further Reading: Investing in Blue-Chip Stocks
Receive News & Ratings for Alteryx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alteryx and related companies with MarketBeat.com's FREE daily email newsletter.